PCN6: MODELLING THE COST-EFFECTIVENESS OF DOCETAXEL IN THE SECOND LINE TREATMENT OF NON-SMALL-CELL LUNG CANCER (NSCLC)
Keyword(s):
Keyword(s):
Cost–effectiveness of second-line nivolumab for platinum-treated advanced non-small-cell lung cancer
2020 ◽
Vol 9
(18)
◽
pp. 1301-1309
Keyword(s):
The Cost
◽
Keyword(s):
Keyword(s):
2019 ◽
Vol 41
(11)
◽
pp. 2308-2320.e11
◽
Keyword(s):
2010 ◽
Vol 38
(1)
◽
pp. 9-21
◽
Keyword(s):
Keyword(s):
Keyword(s):
2011 ◽
Vol 6
(12)
◽
pp. 2097-2103
◽
Keyword(s):